Impact of ECMO on drugs pharmacokinetics;Impact de l'ECMO sur la pharmacocinétique des médicaments

Therapie

Volumn 66, Issue 5, 2011, Pages 405-412

  Hasni, Nesrine ^a   Lemaitre, Florian ^a   Fernandez, Christine ^a,b   Combes, Alain ^a,c   Farinotti, Robert ^a,b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b EA4123   (France)

^c SORBONNE UNIVERSITÉ   (France)

Author keywords

Drugs; Extracorporeal membrane oxygenation (ECMO); Pharmacokinetics

Indexed keywords

ARTICLE; DOSE RESPONSE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG USE; EXTRACORPOREAL OXYGENATION; HUMAN; MEDICAL LITERATURE; PRIORITY JOURNAL;

EID: 84855166611     PISSN: 00405957     EISSN: 19585578     Source Type: Journal    
DOI: 10.2515/therapie/2011054     Document Type: Article

References (38)

1. Combes A, Leprince P, Luyt CE, et al. Assistance cardiorespiratoire par extracorporeal membrane oxygenation (ECMO). Réanimation 2009; 18: 420-7
2. Fay AF, Edlinger C, Vongmany N, et al. Classification et indications des dispositifs d'assistance cardiaque mécanique. ITBM-RBM 2004; 25: 346-54 (Pubitemid 40260445)
3. Buck ML. Pharmacokinetic changes during extracorporeal membrane oxygenation implications for drug therapy of neonates. Clin Pharmacokinet 2003; 42(5): 403-17 (Pubitemid 36649036)
4. Falcoz PE, Capellier G. Principes et indications de l'ECMO en pathologie pulmonaire de l'adulte. Techniques chirurgicales-Thorax 2009; 42-443: 1-14
5. Pavie A, Leprince P, Bonnet N, et al. Apport de l'unité mobile d'assistance circulatoire (UMAC) dans les situations hémodynamiques d'urgence extrême. E-mémoires de l'Académie nationale de chirurgie 2006; 5(3): 56-63
6. Pouard P, Laquay N. Extracorporeal membrane oxygenation (ECMO) en pédiatrie. In: Robert R, Honoré PM, Bastien O (Eds.), les circulations extracorporelles en réanimation. Paris: Elsevier Masson 2006: 505-30
7. Combes A, Leprince P, Luyt CE, et al. Outcomes and long-term quality - of-life of patients suported by extracorporeal membrane oxygenation for refractory cardiogenic shock. Crit Care Med 2008; 36: 1404-11 (Pubitemid 351620652)
8. Delannoy B, Bastien O, Flamens C, et al. Les complications de l'oxygénation extracorporelle (ECMO): à propos de 31 cas. ITBM-RBM 2007; 28: S42-S48
9. Wearden PD, Morell VO, Munoz R. Extracorporeal membrane oxygenation and drug clearance. In: Munoz R, Schmitt CG, Roth SJ, Da cruz E, (Eds.), Handbook of Pediatric Cardiovascular Drugs. 14éme ed. London: Springer; 2008: 215-25
10. Clavey M. Modifications pharmacocinétiques induites par la circulation extracorporelle. Ann Fr Anesth Réanim 1986; 5: 295-305 (Pubitemid 16086820)
11. Mulla H, Lawson G, Woodland ED, et al. Effects of neonatal extracorporeal membrane oxygenation circuits on drug disposition. Curr Ther Res 2000; 61: 838-48
12. Dagan O, Klein J, Gruenwald C, et al. Preliminary studies of the effects of extracorporeal membrane oxygenator on the disposition of common pediatric drugs. Ther Drug Monit 1993; 15: 263-6 (Pubitemid 23237575)
13. Southgate M, Dipiro J, Robertson A. Pharmacokinetics of gentamicin in neonates on extracorporeal membrane oxygenation. Antimicrob Agents Chemother 1989; 33: 817-9 (Pubitemid 19146566)
14. Cohen P, Collart L, Prober CG. Gentamicin pharmacokinetics in neonates undergoing extracorporeal membrane oxygenation. Pediatr Infect Dis J 1990; 9: 562-6 (Pubitemid 20260479)
15. Bhatt-MehtaV, Johnson CE, Schumacher RE. Gentamicin pharmacokinetics in term neonates receiving extracorporeal membrane oxygenation. Pharmacotherapy 1992; 12(1): 28-32
16. Amaker R D, Dipiro JT, Bhatia J. Pharmacokinetics of vancomycin in critically ill infants undergoing extracorporeal membrane oxygenation. Antimicrob Agents Chemother 1996; 40(5): 1139-42 (Pubitemid 26136023)
17. Mulla H, Pooboni S. Population pharmacokinetics of vancomycin in patients receiving extracorporeal membrane oxygenation. Br J Clin Pharmacol 2005; 60(3): 265-75 (Pubitemid 41224134)
18. Mehta N, Halwick DR, Dodson BL, et al. Potential drug sequestration during extracorporeal membrane oxygenation: results from an ex vivo experiment. Intensive Care Med 2007; 33: 1018-24 (Pubitemid 46835404)
19. Ruiz S, Papy E, Da Silva D, et al. Potential voriconazole and caspofungin sequestration during extracorporeal membrane oxygenation. Intensive Care Med 2009; 35: 183-4
20. Spriet I, Annaert P, Meersseman P, et al. Pharmacokinetics of caspofungin and voriconazole in critically ill patients during extracorporeal membrane oxygenation. J Antimicrob Chemother 2009; 63(4): 767-70
21. Hiraoka H, Yamamoto K, Okano N, et al. Changes in drug plasma concentrations of an extensively bound and highly extracted drug, propofol, in response to altered plasma binding. Clin Pharmacol Ther 2004; 75(4): 324-30 (Pubitemid 38471557)
22. Hynynen M, Hammarén E, Rosenberg P. Propofol sequestration within the extracorporeal cicuit. Can J Anaesth 1994; 41(7): 583-8 (Pubitemid 24251806)
23. Mulla H, Lawson G, Von Anrep C, et al. In vitro evaluation of sedative drug losses during extracorporeal membrane oxygenation. Perfusion 2000; 15(1): 21-6 (Pubitemid 30064112)
24. Rosen DA, Rosen KR.Midazolam for sedation in pediatric intensive care unit. Intensive Care Med 1991; 17 Suppl 1: S15-9
25. Mulla H, Lawson G, Peek GJ. Plasma concentrations of midazolam in neonates receiving extracorporeal membrane oxygenation. ASAIO J 2003; 49: 41-7 (Pubitemid 36105578)
26. Mehta V, Annich G. Sedative clearance during extracorporeal membrane oxygenation. Perfusion 2005; 20(6): 309-15 (Pubitemid 41824359)
27. Mulla H, Mc Cormack P, Lawson G, et al. Pharmacokinetics of midazolam in neonates undergoing extracorporeal membrane oxygenation. Anesthesiology 2003; 99: 275-82 (Pubitemid 36909552)
28. Arnold JH, Truog RD, Scavone JM, et al. Changes in pharmacodynamic response to fentanyl in neonates during continuous infusion. J Pediatr 1991; 119(4): 639-43
29. Arnold JH, Robert D, Truog MD, et al. Tolerance and dependence in neonates sedated with fentanyl during extracorporeal membrane oxygenation. Anesthesiology 1990; 73: 1136-40
30. Dagan O, Klein J, Bohn D, et al. Effects of extracorporeal membrane oxygenation on morphine pharmacokinetics in infants. Crit Care Med 1994; 22: 1099-101 (Pubitemid 24219414)
31. Kaussman BD, Zurakowski D, Sullivan L, et al. Evaluation of plasma fentanyl concentrations in infants during cardiopulmonary bypass with low volume circuits. J Cardiothorac Vasc Anesth 2005; 19(3): 316-21 (Pubitemid 40797687)
32. Koren G, Crean P, Klein J, et al. Sequestration of fentanyl by the cardiopulmonary bypass. Eur J Clin Pharmacol 1984; 27: 51-6
33. Leuschen MP, Willett LD, Hoie EB, et al. Plasma fentanyl levels in infants undergoing extracorporeal membrane oxygenation. J Thorac Cardiovasc Surg 1993; 105: 885-91 (Pubitemid 23151818)
34. Elliott E, Buck M. Phenobarbital dosing and pharmacokinetics in a neonate receiving extracorporeal membrane oxygenation. The Annals of pharmacotherapy 1999; 33: 419-22 (Pubitemid 29215807)
35. Green PT, Isham-Schop B, Irmiter JR, et al. Inactivation of heparin during extracorporeal circulation in infants. Clin Pharmacol Ther 1990; 48: 148-53
36. Mulla H, Nabi F, Nichani S, et al. Population pharmacokinetics of theophylline during paediatric extracorporeal membrane oxygenation. Br J Clin Pharmacol 2003; 55: 23-31 (Pubitemid 36110836)
37. Wells TG, Fasules JW, Taylor BJ, et al. Pharmacokinetics and pharmacodynamics of bumetanide in neonates treated with extracorporeal membrane oxygenation. J Pediatr 1992; 121(6): 974-80
38. Kendrick JG, Macready JJ, Kissoon N. Amiodarone treatment of junctional ectopic tachycardia in a neonate receiving extracorporeal membrane oxygenation. Ann Pharmacother 2006; 40: 1872-5 (Pubitemid 44544888)